Stem cell trial success could lead to new heart disease therapies
The key objective of the EU-funded CARE-MI project, which was completed in September 2015, was to evaluate the safety and efficacy of AlloCSC-01, a suspension of allogeneic human cardiac stem cells (CSCs) in patients who ...
Nov 25, 2015
0
12